Skip to main content

Table 4 Subset analyses of hypomagnesemia

From: Correlation between blood magnesium and calcium concentration in patients treated with an anti-EGFR antibody

  Hypomagnesemia
Grade 0 Grade 1< p
No   9 13  
Sexa) Men/Women 6/3 11/2 0.316
Body Hight (cm)b) Mean ± S.D. 160.5 ± 9.6 164.4 ± 7.3 0.556
Body Weight (kg)b) Mean ± S.D. 57.3 ± 7.7 58.6 ± 10.2 0.647
PSa) 0/1or 2 6/3 7/6 0.439
AST (IU/l)b) Mean ± S.D. 20.1 ± 3.3 20.6 ± 5.1 0.794
ALT (IU/l)b) Mean ± S.D. 14.4 ± 7.3 16.0 ± 7.1 0.695
sCre (mg/dl)b) Mean ± S.D. 0.65 ± 0.10 0.79 ± 0.39 0.794
Neu (/mm3)b) Mean ± S.D. 3253 ± 907 4037 ± 1704 0.431
WBC (/mm3)b) Mean ± S.D. 5211 ± 1230 6438 ± 1815 0.144
PLT (/mm3)b) Mean ± S.D. 193,778 ± 43,260 216,308 ± 64,165 0.556
Hb (g/dl)b) Mean ± S.D. 11.83 ± 1.67 11.56 ± 1.83 0.948
Mg (mg/dl)b) Mean ± S.D. 2.14 ± 0.25 2.12 ± 0.21 0.749
Ca (mg/dl)b) Mean ± S.D. 10.00 ± 0.37 9.93 ± 0.32 0.845
Combination regimen FOLFIRI base 6 9  
FOLFOX base 0 2
CPT-11 alone 2 0
Monotherapy 1 2
  1. a)χ2test, b)Mann-Whitney’s U test